Home › Funds › Citigroup Inc › GRCE
Citigroup Inc position in GRCE
GRACE THERAPEUTICS INC · Health Care
Latest position (Q3 2025)2.76K sh
Reported value held$8.19K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 25.00K | $22.82K | New |
| Q1 2023 | 550.00K | $674.58K | Add |
| Q2 2023 | 550.00K | $579.70K | Hold |
| Q3 2023 | 500.00K | $401.90K | Reduce |
| Q4 2023 | 500.00K | $379.69K | Hold |
| Q3 2024 | 3.50M | $2.96M | New |
| Q2 2025 | 1 | $3 | New |
| Q3 2025 | 2.76K | $8.19K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GRCE
- Vanguard Group 423.98K sh · $1.48M · Q4 2025
- Bank of America Corp 494.70K sh · $1.12M · Q2 2026
- Citadel Advisors 402.24K sh · $913.09K · Q2 2026
- Two Sigma Investments 96.89K sh · $219.94K · Q2 2026
- BlackRock Inc 37.53K sh · $85.20K · Q2 2026
- UBS Group AG 16.78K sh · $38.08K · Q2 2026
- Morgan Stanley 9.45K sh · $21.45K · Q2 2026
- Wells Fargo & Co 1.80K sh · $4.09K · Q2 2026